Literature DB >> 9165534

Inhibition of growth of Dictyostelium discoideum amoebae by bisphosphonate drugs is dependent on cellular uptake.

M J Rogers1, X Xiong, X Ji, J Mönkkönen, R G Russell, M P Williamson, F H Ebetino, D J Watts.   

Abstract

PURPOSE: The aim of the study was to determine whether bisphosphonates are internalised by Dictyostelium amoebae and whether cellular uptake is required for their growth-inhibitory effects. Bisphosphonates inhibit growth of amoebae of the slime mould Dictyostelium discoideum, by mechanisms that appear to be similar to those that cause inhibition of osteoclastic bone resorption.
METHODS: Cell-free extracts prepared from amoebae that had been incubated with bisphosphonates were analysed by 31P-n.m.r, spectroscopy or ion-exchange f.p.l.c., to identify the presence of bisphosphonates or bisphosphonate metabolites respectively. The growth-inhibitory effect of bisphosphonates towards Dictyostelium amoebae was also examined under conditions in which pinocytosis was inhibited.
RESULTS: All of the bisphosphonates studied were internalised by Dictyostelium amoebae, probably by fluid-phase pinocytosis, and could be detected in cell-free extracts. Amoebae that were prevented from internalising bisphosphonates by pinocytosis were markedly resistant to the growth-inhibitory effects of these compounds. In addition, bisphosphonates encapsulated within liposomes were more potent growth inhibitors of Dictyostelium owing to enhanced intracellular delivery of bisphosphonates.
CONCLUSIONS: All bisphosphonates inhibit Dictyostelium growth by intracellular mechanisms following internalisation of bisphosphonates by fluid-phase pinocytosis. It is therefore likely that bisphosphonates also affect osteoclasts by interacting with intracellular, rather than extracellular, processes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165534     DOI: 10.1023/a:1012157212793

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.

Authors:  A Carano; S L Teitelbaum; J D Konsek; P H Schlesinger; H C Blair
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 2.  Bisphosphonates: mechanisms of action.

Authors:  G A Rodan; H A Fleisch
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

3.  Effects of 1-hydroxyethylidene-1,1 bisphosphonate and (chloro-4 phenyl) thiomethylene bisphosphonic acid (SR 41319) on the mononuclear cell factor-mediated release of neutral proteinases by articular chondrocytes and synovial cells.

Authors:  X Emonds-Alt; J C Brelière; R Roncucci
Journal:  Biochem Pharmacol       Date:  1985-11-15       Impact factor: 5.858

4.  Caffeine, an inhibitor of endocytosis in Dictyostelium discoideum amoebae.

Authors:  C Gonzalez; G Klein; M Satre
Journal:  J Cell Physiol       Date:  1990-09       Impact factor: 6.384

5.  Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage.

Authors:  M G Cecchini; H Fleisch
Journal:  J Bone Miner Res       Date:  1990-10       Impact factor: 6.741

6.  Cultivation of Dictyostelium discoideum in axenic medium.

Authors:  R Sussman; M Sussman
Journal:  Biochem Biophys Res Commun       Date:  1967-10-11       Impact factor: 3.575

7.  Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.

Authors:  M J Rogers; X Xiong; R J Brown; D J Watts; R G Russell; A V Bayless; F H Ebetino
Journal:  Mol Pharmacol       Date:  1995-02       Impact factor: 4.436

8.  Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.

Authors:  J Mönkkönen; M Taskinen; S O Auriola; A Urtti
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

9.  Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum.

Authors:  M J Rogers; D J Watts; R G Russell; X Ji; X Xiong; G M Blackburn; A V Bayless; F H Ebetino
Journal:  J Bone Miner Res       Date:  1994-07       Impact factor: 6.741

10.  31P-nuclear magnetic resonance analysis of the intracellular pH in the slime mold Dictyostelium discoideum.

Authors:  M Satre; J B Martin
Journal:  Biochem Biophys Res Commun       Date:  1985-10-15       Impact factor: 3.575

View more
  8 in total

1.  The cellular uptake and metabolism of clodronate in RAW 264 macrophages.

Authors:  H Mönkkönen; M J Rogers; N Makkonen; S Niva; S Auriola; J Mönkkönen
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  Therapeutic perspectives.

Authors:  Carmelo E Fiore; Pietra Pennisi; Marianna Tinè
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

3.  Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.

Authors:  J E Fisher; M J Rogers; J M Halasy; S P Luckman; D E Hughes; P J Masarachia; G Wesolowski; R G Russell; G A Rodan; A A Reszka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

4.  A new motif for inhibitors of geranylgeranyl diphosphate synthase.

Authors:  Benjamin J Foust; Cheryl Allen; Sarah A Holstein; David F Wiemer
Journal:  Bioorg Med Chem       Date:  2016-06-10       Impact factor: 3.641

5.  The Electroporation as a Tool for Studying the Role of Plasma Membrane in the Mechanism of Cytotoxicity of Bisphosphonates and Menadione.

Authors:  Mantas Šilkūnas; Rita Saulė; Danutė Batiuškaitė; Gintautas Saulis
Journal:  J Membr Biol       Date:  2016-04-04       Impact factor: 1.843

Review 6.  Bisphophonates in CKD patients with low bone mineral density.

Authors:  Wen-Chih Liu; Jen-Fen Yen; Cheng-Lin Lang; Ming-Tso Yan; Kuo-Cheng Lu
Journal:  ScientificWorldJournal       Date:  2013-12-31

Review 7.  Bone Metastases: An Overview.

Authors:  Filipa Macedo; Katia Ladeira; Filipa Pinho; Nadine Saraiva; Nuno Bonito; Luisa Pinto; Francisco Goncalves
Journal:  Oncol Rev       Date:  2017-05-09

8.  Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation.

Authors:  Mohanad H Nada; Hong Wang; Grefachew Workalemahu; Yoshimasa Tanaka; Craig T Morita
Journal:  J Immunother Cancer       Date:  2017-02-21       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.